Southbridge, MA, United States of America

Elsio Wunder

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Wallingford, CT (US) (2018)
  • Southbridge, MA (US) (2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Elsio Wunder

Introduction

Elsio Wunder is an accomplished inventor based in Southbridge, MA (US). He has made significant contributions to the field of microbiology through his innovative research and inventions. With a total of 2 patents, his work focuses on the development of compositions and methods that have the potential to impact health and disease treatment.

Latest Patents

Wunder's latest patents include groundbreaking work on flagellar-coiling protein 1 (Fcp1)-deficient bacteria. The first patent outlines compositions and methods for preparing these bacteria, which are essential for understanding motility deficiencies. It includes an isolated Fcp1-deficient bacterium and methods for producing motility-deficient bacteria by inhibiting the expression of the wild-type Fcp1 gene. Additionally, this patent discusses methods for stimulating an immune response and treating infectious diseases caused by bacteria through the administration of Fcp1-deficient bacteria. The second patent similarly focuses on the preparation of Leptospira, emphasizing the same innovative approaches to combat bacterial infections.

Career Highlights

Elsio Wunder is affiliated with Yale University, where he conducts his research and develops his inventions. His work has garnered attention in the scientific community for its potential applications in medical treatments and disease prevention.

Collaborations

Wunder collaborates with notable colleagues, including Albert Ko, to further enhance the impact of his research. Their combined expertise contributes to the advancement of knowledge in the field of microbiology.

Conclusion

Elsio Wunder's innovative contributions to the field of microbiology through his patents on Fcp1-deficient bacteria highlight his role as a significant inventor. His work not only advances scientific understanding but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…